Construction, expression andin vitro biological behaviors of Ig scFv fragment in patients with chronic B cell leukemia

Abstract

The expression vector of SmIg scFv fragment was constructed in patient with B cell chronic lymphocyte leukemia (B-CLL) and expressed inE. coli to obtain scFv fragment, and the effect of the protein on the proliferation of stimulated peripheral blood mononuclear cells (PBMC) was investigatedin vitro. Two pairs of primers were designed, and variable region genes of light chain and heavy chain were amplified by PCR respectively from the pGEM-T vectors previously constructed in our laboratory which containing light chain gene or Fd fragment of heavy chain gene. The PCR product was digested, purified and inserted into pHEN2 vector to construct the soluble expression vector pHEN2-scFv. After the induction by IPTG, the scFv protein was identified by SDS-PAGE electrophoresis and purified by Ni-NTA-Chromatography. MTT was used to determine the effect of purified protein on the proliferation of stimulated PBMCin vitro. Plasmid PCR and restriction enzyme digestion of pHEN2-scFv revealed the pHEN2-scFv vector was constructed successfully. Id-scFv protein was expressed in positive clone after induced by IPTG. SDS-PAGE analysis showed that the relative molecular weight of fusion protein was about 30 kD (1 kD=0.9921 ku), which was consistent with the theoretically predicted value. Proliferation of PBMC could be induced by purified Id-scFv. It was suggested that the expression vector of SmIg scFv fragment was constructed successfully, and scFv protein was expressed and secreted from E. coli, which could induce proliferation of PBMC. This may lay an experimental foundation for further rescarch of Id-HSP complex vaccine for B-CLL.

Keywords

B cell chronic lymphocyte leukemia / scFv / SmIg

References

[1] Le GallF, BoveJ M, GarnierM. Engineering of a single-chain variable-fragment (scFv) antibody specific for the stolbur phytoplasma (Mollicute) and its expression in Escherichia coli and tobacco plants. Appl Environ Microbiol, 1998, 64: 4566-4572

[2] ZhuZ, ZapataG, ShalabyR, et al. . High level secretion of a humanized bispecific diabody from Escherichia coli. Biotechnology (NY), 1996, 14: 192-196

[3] WornA, PluckthunA. Stability engineering of antibody single-chain Fv fragments. J Mol Biol, 2001, 305: 989-1010

[4] RaagR, WhitlowM. Single-chain Fvs. FASEB J, 1995, 9(1): 73-80

[5] TangY, JiangN, ParakhC, et al. . Selection of linkers for a catalytic single-chain antibody using phage display technology. J Biol Chem, 1996, 271: 15682-15686

[6] HenneckeF, KrebberC, PluckthunA. Non-repetitive single-chain Fv linkers selected by selectively infective phage (SIP) technology. Protein Eng, 1998, 11: 405-410

[7] HarrisonJ S, Keshavarz-MooreE. Production of antibody fragments in Escherichia coli. Ann N Y Acad Sci, 1996, 782: 143-158

[8] CaseyJ L, KeepP A, ChesterK A, et al. . Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography. J Immunol Methods, 1995, 179: 105-116

[9] LiuD X, LiX Y, WangY. Secretory expression of single chain Fv antibodies inEscherichia coli. Junyi Jinxiu Xueyuan Xuebao (Chinese), 2002, 23(3): 233-235